. 2021 Jun 29;35(8):e23883. doi: 10.1002/jcla.23883

TABLE 1.

Correlation between clinical data of patients and NLR, SII, and NHL

	High NLR group (n = 121)	Low NLR group (n = 95)	χ²	p	High SII group (n = 148)	Low SII group (n = 67)	χ²	p	High NHL group (n = 100)	Low NHL group (n = 116)	χ²	p
	n (%)	n (%)	χ²	p	n (%)	n (%)	χ²	p	n (%)	n (%)	χ²	p
Smoking history
Yes	39 (32)	38 (40)	1.400	0.237	47 (32)	30 (45)	3.103	0.078	33 (33)	44 (38)	0.570	0.451
No	82 (68)	57 (60)	1.400	0.237	101 (68)	37 (55)	3.103	0.078	67 (67)	72 (62)	0.570	0.451
Age (years)
≥60	78 (64)	42 (44)	8.840	p < 0.01	86 (58)	34 (50)	1.240	0.265	61 (61)	59 (51)	2.240	0.135
<60	43 (36)	53 (56)	8.840	p < 0.01	62 (42)	34 (50)	1.240	0.265	39 (39)	57 (49)	2.240	0.135
Gender
Male	95 (79)	68 (72)	1.100	0.294	112 (76)	52 (76)	0.020	0.899	86 (86)	78 (67)	10.340	p < 0.01
Female	26 (21)	26 (27)	1.100	0.294	36 (24)	16 (24)	0.020	0.899	14 (14)	38 (33)	10.340	p < 0.01
Number of tumors
Single	86 (71)	61 (64)	1.150	0.283	103 (70)	44 (65)	0.512	0.474	69 (69)	78 (67)	0.076	0.782
Multiple	35 (29)	34 (36)	1.150	0.283	45 (30)	24 (35)	0.512	0.474	31 (31)	38 (33)	0.076	0.782
Tumor size
≥3cm	39 (32)	30 (32)	0.010	0.919	49 (33)	20 (29)	0.293	0.588	34 (34)	35 (30)	0.362	0.547
<3cm	82 (68)	65 (68)	0.010	0.919	99 (67)	48 (71)	0.293	0.588	66 (66)	81 (70)	0.362	0.547
Pathological grade
Low‐grade	79 (65)	74 (78)	4.090	p < 0.05	96 (65)	57 (84)	8.106	p < 0.01	68 (68)	85 (73)	0.724	0.395
High‐grade	42 (35)	21 (22)	4.090	p < 0.05	52 (35)	11 (16)	8.106	p < 0.01	32 (32)	31 (27)	0.724	0.395
Pathological stage
Ta	96 (79)	84 (88)	3.160	0.075	120 (81)	62 (91)	3.580	0.058	75 (75)	106 (91)	10.611	p < 0.01
T1	25 (21)	11 (12)	3.160	0.075	28 (19)	6 (9)	3.580	0.058	25 (25)	10 (9)	10.611	p < 0.01

Abbreviations: NLR, neutrophil‐lymphocyte ratio; SII, systemic immune inflammation index; NHL, neutrophil hemoglobin product to lymphocyte ratio.